- Home
- BRZE vs KYMR Comparison
BRZE vs KYMR Comparison
Compare BRZE & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRZE
- KYMR
- Stock Information
- Founded
- BRZE 2011
- KYMR 2015
- Country
- BRZE United States
- KYMR United States
- Employees
- BRZE N/A
- KYMR N/A
- Industry
- BRZE Computer Software: Prepackaged Software
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- BRZE Technology
- KYMR Health Care
- Exchange
- BRZE Nasdaq
- KYMR Nasdaq
- Market Cap
- BRZE 3.0B
- KYMR 3.1B
- IPO Year
- BRZE 2021
- KYMR 2020
- Fundamental
- Price
- BRZE $26.80
- KYMR $44.91
- Analyst Decision
- BRZE Strong Buy
- KYMR Strong Buy
- Analyst Count
- BRZE 20
- KYMR 16
- Target Price
- BRZE $46.30
- KYMR $58.94
- AVG Volume (30 Days)
- BRZE 1.7M
- KYMR 875.7K
- Earning Date
- BRZE 09-04-2025
- KYMR 08-06-2025
- Dividend Yield
- BRZE N/A
- KYMR N/A
- EPS Growth
- BRZE N/A
- KYMR N/A
- EPS
- BRZE N/A
- KYMR N/A
- Revenue
- BRZE $620,010,000.00
- KYMR $58,885,000.00
- Revenue This Year
- BRZE $20.94
- KYMR $58.26
- Revenue Next Year
- BRZE $16.79
- KYMR N/A
- P/E Ratio
- BRZE N/A
- KYMR N/A
- Revenue Growth
- BRZE 22.66
- KYMR N/A
- 52 Week Low
- BRZE $25.22
- KYMR $19.45
- 52 Week High
- BRZE $48.33
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- BRZE 39.78
- KYMR 56.82
- Support Level
- BRZE $26.35
- KYMR $43.56
- Resistance Level
- BRZE $29.15
- KYMR $45.83
- Average True Range (ATR)
- BRZE 0.99
- KYMR 1.77
- MACD
- BRZE 0.17
- KYMR -0.49
- Stochastic Oscillator
- BRZE 38.27
- KYMR 51.65
About BRZE Braze Inc.
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.